April 22, 2011
[04/22/2011] FDA has updated the Tysabri (natalizumab) Prescribing Information to give new information about the size of the risk of progressive multifocal leukoencephalopathy (PML), a rare […]
February 2, 2011
Children born with cardiac and other congenital birth defects have potentially been linked to use of the SSRI class of antidepressant drugs, including Lexapro (Generic: escitalopram). […]
January 13, 2011
Children born with cardiac and other congenital birth defects have potentially been linked to use of the SSRI class of antidepressant drugs, including Celexa (Generic: citalopram). […]
December 17, 2010
Children born with cardiac and other congenital birth defects have possibly been linked to use of the anti-depressant drug bupropion (Aplenzin, Wellbutrin, Wellbutrin SR, Wellbutrin XL, […]
December 17, 2010
Children born with a heart defect, lung defect or other congenital birth defects have possibly been linked to use of the antidepressant drug Zoloft. Research suggests […]
August 19, 2010
Inspections, Compliance, Enforcement, and Criminal Investigations Depuy Orthopaedics, Inc. 8/19/10 Department of Health and Human Services Public Health ServiceFood and Drug Administration 10903 New Hampshire Avenue […]
March 17, 2010
New safety information will be included in the Tysabri (natalizumab) drug label and patient Medication Guide: The risk of developing progressive multifocal leukoencephalopathy (PML) increases with […]
February 1, 2010
Depakote, a widely used anti-epileptic and anti-seizure drug, is manufactered and marketed by Abbott Laboratories. Depakote was first approved by the US FDA and introduced in the US […]
January 5, 2010
Recall Class: Class I Date Recall Initiated: November 6, 2009 Product Name: Trailblazer Support Catheter Model Numbers Lot Numbers SC-014-135, SC-018-090,SC-035-065, SC-035-135,SC-014-150, SC-018-150,SC-035-090, SC-035-150. 7828282, 7792290, […]